v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 2 $ 40,973 $ 3 $ (48,229) $ (7,251)
Balance (in Shares) at Dec. 31, 2024 22,594,877        
Stock-based compensation 200 200
Issuance of Common Stock from debt offering 377 377
Issuance of Common Stock from debt offering (in Shares) 2,028,846        
Issuance of common stock to pay convertible debt 1,433 1,433
Issuance of common stock to pay convertible debt (in Shares) 610,426        
Sale of common stock (net of $19K issuance costs)   543 543
Sale of common stock (net of $19K issuance costs) (in Shares) 310,925        
Stock option exercises 158 158
Stock option exercises (in Shares) 43,047        
Cumulative translation adjustment 17 17
Net loss 2,897 2,897
Balance at Mar. 31, 2025 $ 2 43,684 20 (45,332) (1,626)
Balance (in Shares) at Mar. 31, 2025 25,588,121        
Balance at Dec. 31, 2024 $ 2 40,973 3 (48,229) (7,251)
Balance (in Shares) at Dec. 31, 2024 22,594,877        
Net loss         (5,071)
Balance at Jun. 30, 2025 $ 2 44,095 52 (53,300) (9,151)
Balance (in Shares) at Jun. 30, 2025 25,737,820        
Balance at Mar. 31, 2025 $ 2 43,684 20 (45,332) (1,626)
Balance (in Shares) at Mar. 31, 2025 25,588,121        
Stock-based compensation 411 411
Issuance of Common Stock from debt offering
Issuance of Common Stock from debt offering (in Shares) 40,000        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 109,699        
Cumulative translation adjustment 32 32
Net loss (7,968) (7,968)
Balance at Jun. 30, 2025 $ 2 44,095 52 (53,300) (9,151)
Balance (in Shares) at Jun. 30, 2025 25,737,820        
Balance at Dec. 31, 2025 $ 3 50,030 40 (55,800) (5,727)
Balance (in Shares) at Dec. 31, 2025 30,688,895        
Stock-based compensation 183 183
Stock option exercises 156 156
Stock option exercises (in Shares) 150,000        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 50,000        
Cumulative translation adjustment (10) (10)
Pre-funded warrant exercises
Pre-funded warrant exercises (in Shares) 935,000        
Net loss (3,412) (3,412)
Balance at Mar. 31, 2026 $ 3 50,369 30 (59,212) (8,810)
Balance (in Shares) at Mar. 31, 2026 31,823,895        
Balance at Dec. 31, 2025 $ 3 50,030 40 (55,800) (5,727)
Balance (in Shares) at Dec. 31, 2025 30,688,895        
Net loss         (7,588)
Balance at Jun. 30, 2026 $ 3 51,302 29 (63,388) (12,054)
Balance (in Shares) at Jun. 30, 2026 32,184,928        
Balance at Mar. 31, 2026 $ 3 50,369 30 (59,212) (8,810)
Balance (in Shares) at Mar. 31, 2026 31,823,895        
Stock-based compensation 807 807
Stock option exercises 24 24
Stock option exercises (in Shares) 18,333        
Issuance of common stock under the SEPA 5 5
Issuance of common stock under the SEPA (in Shares) 3,000        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 309,700        
Cumulative translation adjustment (1) (1)
Warrant exercises 97 97
Warrant exercises (in Shares) 30,000        
Net loss (4,176) (4,176)
Balance at Jun. 30, 2026 $ 3 $ 51,302 $ 29 $ (63,388) $ (12,054)
Balance (in Shares) at Jun. 30, 2026 32,184,928